Lista de obras - Guillermo Guenechea - Dominio Público Uruguay

A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells.

artículo científico publicado en 2010

AM218, a new polyanionic polysaccharide, induces radioprotection in mice when administered shortly before irradiation

scientific article published on 01 January 1997

Advances in the gene therapy of monogenic blood cell diseases

scientific article published on 24 June 2019

Brief report: impaired cell reprogramming in nonhomologous end joining deficient cells.

artículo científico publicado en 2013

Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy

artículo científico publicado en 2007

Conversion of human fibroblasts into monocyte-like progenitor cells

artículo científico publicado en 2014

DNA delivery to 'ex vivo' human liver segments.

artículo científico publicado en 2011

Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia

artículo científico publicado en 2010

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

artículo científico publicado en 2009

Distinct classes of human stem cells that differ in proliferative and self-renewal potential

artículo científico publicado en 2001

Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors.

artículo científico publicado en 2018

Engraftment and in vivo proliferation advantage of gene corrected mobilized CD34(+) cells from Fanconi anemia patients.

artículo científico

Ex vivo expansion of umbilical cord blood (UCB) CD34(+) cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrins

scientific article published on 01 October 2001

GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells

scientific article published on 22 January 2019

Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

artículo científico publicado en 2015

Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy

artículo científico publicado en 2014

Immunomagnetic enrichment of human and mouse hematopoietic stem cells for gene therapy applications

artículo científico publicado en 2009

In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1.

artículo científico publicado en 2008

Lentiviral vector integration sites in human NOD/SCID repopulating cells

artículo científico publicado en 2006

Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.

artículo científico publicado en 2015

Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients

artículo científico publicado en 2009

Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency.

artículo científico publicado en 2018

Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening

artículo científico publicado en 2017

Optimization of lentiviral vectors for the gene therapy of fanconi anemia

article

Parvovirus infection suppresses long-term repopulating hematopoietic stem cells

artículo científico publicado en 2003

Preclinical gene therapy studies of fanconi anemia with lentiviral vectors

article

Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11

scientific article published on 01 May 1999

Radioprotection mediated by the haemopoietic stimulation conferred by AM5: a protein-associated polysaccharide

scientific article published on 01 July 1992

Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice

artículo científico publicado en 2004

Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia

scientific article published on 09 September 2019

Targeted gene therapy into a safe harbor site in human hematopoietic progenitor cells

scientific article published on 26 March 2020

The role of the vav promoter in gene therapy: Safer vectors with weaker and stable expression

article

Transduction of Human CD34+CD38- Bone Marrow and Cord Blood-Derived SCID-Repopulating Cells with Third-Generation Lentiviral Vectors

artículo científico publicado en 2000

Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.

artículo científico publicado en 2008

Lista de obras de Guillermo Guenechea

A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells.

AM218, a new polyanionic polysaccharide, induces radioprotection in mice when administered shortly before irradiation

Advances in the gene therapy of monogenic blood cell diseases

Brief report: impaired cell reprogramming in nonhomologous end joining deficient cells.

Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy

Conversion of human fibroblasts into monocyte-like progenitor cells

DNA delivery to 'ex vivo' human liver segments.

Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

Distinct classes of human stem cells that differ in proliferative and self-renewal potential

Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors.

Engraftment and in vivo proliferation advantage of gene corrected mobilized CD34(+) cells from Fanconi anemia patients.

Ex vivo expansion of umbilical cord blood (UCB) CD34(+) cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrins

GSE4 peptide suppresses oxidative and telomere deficiencies in ataxia telangiectasia patient cells

Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.

Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy

Immunomagnetic enrichment of human and mouse hematopoietic stem cells for gene therapy applications

In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1.

Lentiviral vector integration sites in human NOD/SCID repopulating cells

Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.

Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients

Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency.

Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening

Optimization of lentiviral vectors for the gene therapy of fanconi anemia

Parvovirus infection suppresses long-term repopulating hematopoietic stem cells

Preclinical gene therapy studies of fanconi anemia with lentiviral vectors

Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11

Radioprotection mediated by the haemopoietic stimulation conferred by AM5: a protein-associated polysaccharide

Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice

Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia

Targeted gene therapy into a safe harbor site in human hematopoietic progenitor cells

The role of the vav promoter in gene therapy: Safer vectors with weaker and stable expression

Transduction of Human CD34+CD38- Bone Marrow and Cord Blood-Derived SCID-Repopulating Cells with Third-Generation Lentiviral Vectors

Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.